Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 4 Open-market sale EVP/Chief Scientific Officer sold 10,238 shares at an average $37.41 ($383,028)
  2. 10-Q Report Quarterly Report
  3. 8-K Event Material agreement · Agreement ended · Results of operations
  4. 4 Open-market sale EVP/Chief Scientific Officer sold 3,000 shares at $32.22 ($96,660)
  5. 8-K Event Material agreement · Other events
  6. 424B5 Offering Prospectus
  7. S-3ASR Offering Registration Statement
  8. 8-K Event Shareholder vote results
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 424B5 Offering Prospectus
  15. 8-K Event Material agreement
  16. 4 Open-market sale EVP/Chief Scientific Officer sold 151 shares at $25.28 ($3,817)
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. 8-K Event Executive or director change
  20. DEFA14A Proxy Proxy Materials

Page 20 of 37 · 731 filings